Power Law company profile

Asarina Pharma

Biotech & Life Sciences · Solna kommun, Sweden · Founded 2006 · IPO 2018 Thoroughbred

Developing novel and targeted products to treat women with severe symptoms associated with the menstrual cycle

Valuation

$55M

Market cap · 2026

Revenue

$261M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

2 investors on Asarina Pharma's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 2 investors entered at this stage

Eurazeo

Kurma Partners

Global footprint

Where Asarina Pharma has talent and traffic

Workforce by country

2 countries with
team presence

🇱🇹 Lithuania69.4%

🇸🇪 Sweden61.1%

2 countries shown

Web traffic by country

2K monthly visits
across markets

🇺🇸 United States60%

🇨🇦 Canada30%

🇿🇦 South Africa0%

🇩🇪 Germany0%

🇨🇭 Switzerland0%

Top 5 markets shown

Market sentiment

What the market is saying about Asarina Pharma

An AI-synthesized read of the highest-engagement posts about Asarina Pharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Asarina Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles